Data as at IST. Index data may be delayed by up to 20 minutes. For real-time updates, kindly refer to the BSE and NSE websites.
Gland Pharma Share Price
Know More₹1,581.95 25.15 (1.62%)
04:01 PM, 12-Mar-2025BSE : 543245
NSE : GLAND
Sector : Health care
ISIN Code : INE068V01023
- BSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 12-Mar-2025 | 04:01 PM IST
| Market Cap (₹ Cr) | 26,071 |
Traded Value (₹ Cr) | 1.91 |
Volume (Shares) | 12,103 |
Face Value (₹) | 1 |
52-Week High (₹) | 2,220.95 |
52-Week High Date | 06-Aug-2024 |
52-Week Low (₹) | 1,200.00 |
52-Week Low Date | 07-Apr-2025 |
All Time High (₹) | 4,350.00 |
All Time High Date | 12-Aug-2021 |
All Time Low (₹) | 861.50 |
All Time Low Date | 22-May-2023 |
Gland Pharma Ltd
Gland Pharma Ltd News
Gland Pharma Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 26,071 |
| EPS - TTM (₹) [C] | 42.75 |
| P/E Ratio (X) [C] | 37.00 |
| Face Value (₹) | 1 |
| Latest Dividend (%) | - |
| Latest Dividend Date | - |
| Dividend Yield (%) | 1.27 |
| Book Value Share (₹) [C] | 533.39 |
| P/B Ratio (₹) [C] | 2.97 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| HDFC Mid-Cap Opportunities Fund (G) | 862.10 | 55,51,922 | 1.28 |
| HDFC Mid-Cap Opportunities Fund (IDCW) | 862.10 | 55,51,922 | 1.28 |
| HDFC Mid-Cap Opportunities Fund - Direct (IDCW) | 862.10 | 55,51,922 | 1.28 |
| HDFC Mid-Cap Opportunities Fund - Direct (G) | 862.10 | 55,51,922 | 1.28 |
| SBI Large & Midcap Fund (IDCW) | 450.31 | 29,00,000 | 1.64 |
| SBI Large & Midcap Fund (G) | 450.31 | 29,00,000 | 1.64 |
| SBI Large & Midcap Fund - Direct (G) | 450.31 | 29,00,000 | 1.64 |
| SBI Large & Midcap Fund - Direct (IDCW) | 450.31 | 29,00,000 | 1.64 |
| ICICI Pru India Opportunities Fund (G) | 416.91 | 26,84,881 | 1.75 |
| ICICI Pru India Opportunities Fund (IDCW) | 416.91 | 26,84,881 | 1.75 |
Load more
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| 04-Feb-2025 | Elara Capital | Buy | 1,841 | |
| 06-Nov-2024 | Motilal Oswal | Buy | 1,970 |
Stock Strength
| Today's Low/High (₹) | 1,554.70 1,620.95 |
| Week Low/High (₹) | 1,215.60 1,620.95 |
| Month Low/High (₹) | 1,215.60 1,620.95 |
| Year Low/High (₹) | 1,200.00 2,221.00 |
| All time Low/High (₹) | 861.50 4,350.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 16.57% | 16.41% | 22.97% | 27.64% |
| 1 Month | 0.31% | 0.21% | 19.03% | 23.24% |
| 3 Month | -14.24% | -14.43% | 19.93% | 24.47% |
| 6 Month | -30.14% | -30.33% | 25.04% | 29.23% |
| 1 Year | -55.74% | -55.88% | 24.11% | 27.96% |
| 3 Year | - | - | 82.98% | 91.93% |
Company Info
Company Information
Director : QIYU CHEN
Company Sec. & Compli. Officer : SAMPATH KUMAR PALLERLAMUDI
Registered Office: Sy No 143-148 150&151 Nr Gandi, X Roads D P Pally Dundigal,Hyderabad,Telangana-500043 Ph: 91-40-30510999
FAQs about Gland Pharma Ltd
1. What's the Gland Pharma Ltd share price today?
Gland Pharma Ltd share price was Rs 1,581.95 at 04:01 PM IST on 12th Mar 2025. Gland Pharma Ltd share price was up by 1.62% over the previous closing price of Rs 1,556.80. Gland Pharma Ltd share price trend:
- Last 1 Month: Gland Pharma Ltd share price moved up by 0.31% on BSE.
- Last 3 Months: Gland Pharma Ltd share price moved down by 14.24% on BSE.
- Last 12 Months: Gland Pharma Ltd share price moved down by 55.74% on BSE.
2. How can I quickly analyse the performance of the Gland Pharma Ltd stock?
The performance of the Gland Pharma Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 37.00
- Price to book value ratio is 2.97
- Dividend yield of 1.27
- The EPS (trailing 12 months) of the Gland Pharma Ltd stock is Rs 42.75
3. What is the market cap of Gland Pharma Ltd?
Gland Pharma Ltd has a market capitalisation of Rs 26,071 crore.
4. What is Gland Pharma Ltd's 52-week high/low share price?
The Gland Pharma Ltd’s 52-week high share price is Rs 2,220.95 and 52-week low share price is Rs 1,200.00.
5. Is the Gland Pharma Ltd profitable?
On a consolidated basis, Gland Pharma Ltd reported a profit of Rs 204.69 crore on a total income of Rs 1,442.55 crore for the quarter ended 2024.
6. Which are Gland Pharma Ltd’s peers in the Health care sector?
Gland Pharma Ltd’s top 5 peers in the Health care sector are Laurus Labs, Suven Pharma, Piramal Pharma, Gland Pharma, J B Chemicals &, Wockhardt, Astrazeneca Phar.
7. Who owns how much in Gland Pharma Ltd?
Key changes to the Gland Pharma Ltd shareholding are as follows:
- Promoter holding in Gland Pharma Ltd has gone down to 57.86 per cent as of Dec 2022 from 58.00 per cent as of Mar 2022.
